Covea Finance grew its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 28.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 136,901 shares of the industrial products company's stock after buying an additional 30,615 shares during the period. Covea Finance owned 0.06% of Xylem worth $16,354,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Xylem by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock worth $3,323,325,000 after acquiring an additional 303,854 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Xylem by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock worth $671,623,000 after purchasing an additional 135,492 shares in the last quarter. Impax Asset Management Group plc boosted its stake in Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after purchasing an additional 3,883,845 shares during the period. Royal Bank of Canada increased its position in shares of Xylem by 7.9% during the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock valued at $506,985,000 after buying an additional 320,500 shares during the period. Finally, Invesco Ltd. increased its position in shares of Xylem by 9.8% during the fourth quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock valued at $465,229,000 after buying an additional 359,276 shares during the period. Institutional investors own 87.96% of the company's stock.
Xylem Trading Up 1.4%
XYL traded up $1.80 on Tuesday, hitting $127.29. 1,123,129 shares of the company were exchanged, compared to its average volume of 1,401,514. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.41 and a current ratio of 1.89. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $143.50. The firm has a fifty day simple moving average of $122.57 and a two-hundred day simple moving average of $121.64. The stock has a market capitalization of $30.97 billion, a PE ratio of 34.22, a price-to-earnings-growth ratio of 2.27 and a beta of 1.13.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. The company had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.04 billion. Xylem had a net margin of 10.54% and a return on equity of 10.12%. The firm's revenue was up 1.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.90 EPS. Sell-side analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Thursday, May 29th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a yield of 1.26%. Xylem's dividend payout ratio is presently 43.01%.
Wall Street Analysts Forecast Growth
XYL has been the subject of several analyst reports. Robert W. Baird cut their price target on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Citigroup lowered their target price on shares of Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Stifel Nicolaus boosted their price target on shares of Xylem from $140.00 to $141.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Raymond James Financial upgraded Xylem to a "hold" rating in a research report on Thursday, May 15th. Finally, Royal Bank Of Canada boosted their target price on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Xylem has an average rating of "Moderate Buy" and an average price target of $143.71.
Check Out Our Latest Report on Xylem
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.